Resveratrol Supplementation Reduces Pain and Inflammation in Knee Osteoarthritis Patients Treated with Meloxicam: A Randomized Placebo-Controlled Study

Marouf BH, Hussain SA, Ali ZS, Ahmmad RS · Journal of Medicinal Food

Companion paper of the same trial reporting VAS-100 pain and serum inflammatory markers (IL-1beta, IL-6, TNF-alpha, CRP, C3/C4); the abstract reports significant reductions versus placebo. Effect sizes are deliberately not restated here: the full text is paywalled and could not be obtained for verification, so this record carries the abstract's directional claims only.

Population

The same 110-patient Sulaimani cohort as pmid-30233159 (companion publication)

Intervention

Resveratrol 500 mg once daily for 90 days, added to meloxicam 15 mg/day

Comparator

Placebo (both arms on meloxicam)

Limitations

Same cohort, arms and limitations as pmid-30233159 — this is not an independent trial. Full text not obtainable (paywalled), so per this site's citation rules no specific between-group numbers are recorded from it.